tiprankstipranks
Advertisement
Advertisement
Vor Bio price target lowered to $40 from $55 at Stifel
PremiumThe FlyVor Bio price target lowered to $40 from $55 at Stifel
21d ago
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
Premium
Ratings
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
21d ago
Vor Bio doses first patient in UPSTREAM SjD study
Premium
The Fly
Vor Bio doses first patient in UPSTREAM SjD study
21d ago
Vor Bio initiated with an Overweight at Wells Fargo
PremiumThe FlyVor Bio initiated with an Overweight at Wells Fargo
1M ago
VOR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VOR Earnings this Week: How Will it Perform?
1M ago
Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
Premium
The Fly
Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
2M ago
Vor Bio price target lowered to $46 from $64 at Baird
PremiumThe FlyVor Bio price target lowered to $46 from $64 at Baird
4M ago
Vor Bio price target lowered to $40 from $43 at JPMorgan
Premium
The Fly
Vor Bio price target lowered to $40 from $43 at JPMorgan
4M ago
Vor Biopharma strengthens board following $150M private placement
Premium
Company Announcements
Vor Biopharma strengthens board following $150M private placement
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100